enow.com Web Search

  1. Ad

    related to: tyrosine kinase inhibitor side effects

Search results

  1. Results from the WOW.Com Content Network
  2. VEGFR-2 inhibitor - Wikipedia

    en.wikipedia.org/wiki/VEGFR-2_inhibitor

    Sorafenib is a small molecule inhibitor of many tyrosine kinase receptors such as VEGFR-2. Side effects are in most cases mild to moderate such as rash, hand-foot skin reaction, diarrhea and dermatitis, and occur in about 33-38% patients using sorafenib. Other side effects are mild hypertension, leukopenia and bleeding. Uncommon side effects ...

  3. Imatinib - Wikipedia

    en.wikipedia.org/wiki/Imatinib

    Imatinib use may cause lightening/depigmentation or darkening/repigmentation of hair (as is the case with some other tyrosine kinase inhibitors) and/or skin as well as hyperpigmentation of the gingiva. The median onset of hair color change is 4 weeks after initiation of therapy (but may occur over a year after initiation), is dose-dependent ...

  4. Tyrosine kinase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Tyrosine_kinase_inhibitor

    A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation of many proteins by signal transduction cascades. The proteins are activated by adding a phosphate group to the protein (phosphorylation), a step that TKIs inhibit. TKIs are typically used as ...

  5. Tyrosine kinase - Wikipedia

    en.wikipedia.org/wiki/Tyrosine_kinase

    The side-effects of Gefitinib oral treatment once per day were considered significant. ... Sunitinib is an oral tyrosine kinase inhibitor that acts upon vascular ...

  6. Nilotinib - Wikipedia

    en.wikipedia.org/wiki/Nilotinib

    Other serious side effects may include QT prolongation, sudden death, pancreatitis, and liver problems. [7] It is not safe for use during pregnancy. [7] Nilotinib is a Bcr-Abl tyrosine kinase inhibitor and works by interfering with signalling within the cancer cell. [3] [7] Nilotinib was approved for medical use in the United States in 2007.

  7. Repotrectinib - Wikipedia

    en.wikipedia.org/wiki/Repotrectinib

    Repotrectinib is an inhibitor of proto-oncogene tyrosine-protein kinase ROS1 (ROS1) and of the tropomyosin receptor tyrosine kinases (TRKs) TRKA, TRKB, and TRKC. [1] The most common adverse reactions include dizziness, dysgeusia, peripheral neuropathy, constipation, dyspnea, ataxia, fatigue, cognitive disorders, and muscular weakness. [2]

  8. Tivozanib - Wikipedia

    en.wikipedia.org/wiki/Tivozanib

    It is an oral VEGF receptor tyrosine kinase inhibitor. [3] The most common side effects include fatigue (tiredness), hypertension (high blood pressure), diarrhea, decreased appetite, nausea, dysphonia (voice changes), hypothyroidism, cough, and stomatitis. [4] [3] [5]

  9. Osimertinib - Wikipedia

    en.wikipedia.org/wiki/Osimertinib

    [7] [8] It is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor. The most common side effects include diarrhea, rash, musculoskeletal pain, dry skin, skin inflammation around nails, sore mouth, fatigue and cough. [9]

  1. Ad

    related to: tyrosine kinase inhibitor side effects